For decades, doctors and scientists have predicted that personalized medicine—tailoring drug doses and combinations to people's specific diseases and body chemistry—would be the future of health care.
Apr 7, 2016
0
46
An analysis of data from a randomized clinical trial for patients with stage 3 colon cancer found that those with PIK3CA mutations who took celecoxib, an anti-inflammatory drug, after surgery lived significantly longer and ...
Jun 18, 2024
0
1
Exhaled breath may be very promising alternative to blood for the therapeutic monitoring of antibiotics, the ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) will hear.
Apr 29, 2024
0
0
When an autopsy revealed that actor Matthew Perry died of "acute effects of ketamine," it put fresh attention on an ongoing debate in the field of psychiatry: What's the right balance between expanding access to a drug that ...
Feb 27, 2024
0
32
The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday.
Dec 6, 2023
0
3
A new Northwestern University study—led by Bernard Black of Northwestern's Pritzker School of Law and Kellogg School of Management—suggests that the U.S. could have saved many lives by authorizing a COVID-19 booster dose ...
Dec 5, 2023
0
2
The diabetes drug Mounjaro prompted more weight loss among overweight and obese adults than Ozempic did in a real-world setting, researchers report.
Nov 29, 2023
0
4
If you've ever trekked to your local pharmacy to treat a stuffy nose, it's likely you were disturbed by an FDA panel's conclusion that a key ingredient in over-the-counter oral cold medications works no better than a placebo.
Sep 14, 2023
0
4
What if treating obesity could be as easy as popping an effective pill?
Jun 26, 2023
0
24
Danish drugmaker Novo Nordisk said Thursday it will limit distribution of its low-dose versions of the wildly popular weight-loss drug Wegovy, to ensure that people already taking the drug will have enough supply.
May 5, 2023
0
2
